Teva Pharmaceutical Industries Limited (TEVJF)

TEVJF Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	40,025	35,807	25,006	11,703	10,129	8,835
Market Cap Growth	60.28%	43.19%	113.68%	15.54%	14.65%	-16.46%
Enterprise Value	53,703	50,699	41,281	30,334	30,275	31,945
Last Close Price	28.36	28.61	18.50	8.62	8.94	8.65
PE Ratio	28.39	25.40	-	-	-	21.19
PS Ratio	2.32	2.08	1.51	0.74	0.68	0.56
PB Ratio	5.06	4.52	4.37	1.44	1.18	0.79
P/FCF Ratio	34.86	31.19	33.39	13.90	9.72	37.44
P/OCF Ratio	24.27	21.71	20.05	8.56	6.37	11.07
EV/Sales Ratio	3.11	2.94	2.50	1.91	2.03	2.01
EV/EBITDA Ratio	10.52	13.05	9.32	7.00	7.63	7.25
EV/EBIT Ratio	13.54	17.58	12.24	9.54	11.37	10.38
EV/FCF Ratio	46.78	44.16	55.12	36.03	29.06	135.36
Debt / Equity Ratio	2.16	2.16	3.18	2.50	2.52	2.10
Debt / EBITDA Ratio	4.24	4.24	3.98	4.53	5.26	5.19
Debt / FCF Ratio	14.89	14.89	24.28	24.08	20.80	99.97
Asset Turnover	0.43	0.43	0.40	0.36	0.33	0.32
Inventory Turnover	2.69	2.69	2.41	2.09	2.08	2.02
Quick Ratio	0.54	0.54	0.50	0.54	0.57	0.61
Current Ratio	1.04	1.04	0.98	1.02	1.05	1.14
Return on Equity (ROE)	20.79%	20.79%	-28.30%	-7.36%	-25.19%	4.09%
Return on Assets (ROA)	4.50%	4.50%	5.09%	4.54%	3.63%	3.91%
Return on Invested Capital (ROIC)	13.23%	13.71%	14.73%	12.08%	8.85%	6.18%
Return on Capital Employed (ROCE)	10.60%	10.60%	12.70%	10.20%	8.20%	8.40%
Earnings Yield	3.52%	3.94%	-6.55%	-4.78%	-24.15%	4.72%
FCF Yield	2.87%	3.21%	3.00%	7.20%	10.29%	2.67%
Buyback Yield / Dilution	-2.83%	-2.83%	-1.07%	-0.81%	-0.27%	-1.10%
Total Shareholder Return	-2.83%	-2.83%	-1.07%	-0.81%	-0.27%	-1.10%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.